News & Blog

Keep up to date with our latest product news, information and events. We’ll also share our expert
insights into the world of genomic healthcare.

Introducing Whole Genome Sequencing service

March 8, 2021

Government regulations, recently announced in the UK, now require Whole Genome Sequencing to be carried out as part of the minimum standards for COVID-19 tests for people arriving in England. In order to support SARS-CoV-2 testing laboratories, we have introduced a Whole Genome Sequencing service.

Read More

What’s in a name?

December 18, 2020

When Chris Sale and Lee Silcock founded Nonacus in 2015 they had one singular purpose- To develop non-invasive DNA tests that would change the way genomic diagnostics was done. Choosing a name that would reflect this mission wasn’t easy. Find out why they went with Nonacus.

Read More

Delivering the potential of cancer genomics to patients

June 15, 2020

This week Nonacus Ltd announced a partnership with Dante Labs and Cambridge Cancer Genomics which aims to build the most comprehensive and patient-centric tumour profiling service enabling improved cancer patient management, treatment and monitoring.

Read More

Nonacus wins Government grant to validate rapid sequencing based surveillance testing for COVID-19.

May 28, 2020

Nonacus was recently awarded an Innovate UK grant, to validate a novel, rapid method for sequencing respiratory viral genomes using nanopore sequencing. This method will provide more comprehensive information about the Sars-CoV-2 genome to support a post pandemic world and, with a respiratory viral panel in the pipeline, will provide surveillance of other respiratory diseases too. So, if your cough is not due to COVID-19, you will be able to find out which respiratory virus is causing it.

Read More
Gluten free

No Gluten Required

May 27, 2020

Nonacus scientists, together with researchers at the University of Cambridge, are working on the development of a novel, non-invasive test for coeliac disease that works even if the patient is already on a gluten-free diet.

Read More

UK firm develops coronavirus spit test which could be done at home

April 17, 2020

Suspected coronavirus patients could be asked to spit into a tube and post the sample to a lab, under plans for a new test being developed by a British firm. Read the interview with Nonacus Ltd in the Sunday Telegraph on how a partnership with Chronomics has led to the development of a spit test for COVID-19.

Read More

Covid-19. Can we help?

March 24, 2020

The impact of the coronavirus is being felt right across the UK and I hope that you, your family and your friends remain safe and well.

With yesterday’s announcement from the government, we know that this impact will be wide ranging and may be having a knock on effect on your laboratory. We are hearing of laboratory closures during the self-isolation period and labs operating with a skeleton staff, all of which puts pressure on laboratory services.

Read More
Exome sequencing for cytogeneticists

Nonacus introduces ExomeCG product to simplify molecular and cytogenomics data generation and interpretation

October 16, 2019

Birmingham, UK, 16 October 2019: Nonacus Ltd, a UK based precision medicine company and manufacturer of ultra-sensitive next-generation sequencing (NGS) products, has announced the launch of ExomeCG, a new product to simplify the generation and interpretation of molecular and cytogenomic data. The new product has been co-developed with digital health technology company, Congenica Ltd, which specialises in software solutions that enable accelerated interpretation of complex genomic data to improve disease diagnosis.

Read More